Skip to main content

nicotine polacrilex

NDC 37808-948 · H E B

Generic namenicotine
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength4 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

37808-948-03 — 1 CONTAINER in 1 CARTON (37808-948-03) / 24 LOZENGE in 1 CONTAINER

37808-948-10 — 4 CONTAINER in 1 CARTON (37808-948-10) / 27 LOZENGE in 1 CONTAINER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

37808-707 — nicotine, 37808-711 — nicotine, 37808-739 — nicotine, 37808-781 — nicotine polacrilex, 37808-820 — Nicotine Polacrilex, 37808-821 — Nicotine Polacrilex, 37808-849 — nicotine polacrilex, 37808-863 — nicotine polacrilex, 37808-900 — nicotine, 37808-909 — nicotine polacrilex, 41250-029 — Nicotine Polacrilex, 41250-170 — Nicotine Polacrilex, 41250-190 — Nicotine polacrilex, 41250-201 — Nicotine polarilex, 41250-209 — Nicotine polacrilex, 41250-344 — Nicotine Polacrilex, 41250-424 — Nicotine Polacrilex, 41250-456 — Nicotine Polacrilex, 41250-510 — Nicotine Polacrilex, 41250-529 — nicotine polacrilex, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels